114 related articles for article (PubMed ID: 25515700)
1. MiR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3.
Tang G; Wu J; Xiao G; Huo L
Mol Med Rep; 2015 Apr; 11(4):2838-44. PubMed ID: 25515700
[TBL] [Abstract][Full Text] [Related]
2. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
Wang J; Sai K; Chen FR; Chen ZP
Cancer Chemother Pharmacol; 2013 Jul; 72(1):147-58. PubMed ID: 23645289
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long non-coding RNA LINC00467 inhibits glioma cell progression via modulation of E2F3 targeted by miR-200a.
Gao S; Duan H; An D; Yi X; Li J; Liao C
Cell Cycle; 2020 Aug; 19(16):2040-2053. PubMed ID: 32684096
[TBL] [Abstract][Full Text] [Related]
4. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
Han J; Chen Q
Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
6. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
[TBL] [Abstract][Full Text] [Related]
8. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.
Zhu D; Tu M; Zeng B; Cai L; Zheng W; Su Z; Yu Z
Cancer Med; 2017 Feb; 6(2):452-462. PubMed ID: 28064447
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis.
Lan J; Xue Y; Chen H; Zhao S; Wu Z; Fang J; Han C; Lou M
FEBS Lett; 2014 Sep; 588(18):3333-9. PubMed ID: 25080009
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
13. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
14. miR‑210‑3p regulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3.
Jin Y; Wei J; Xu S; Guan F; Yin L; Zhu H
Mol Med Rep; 2019 Jun; 19(6):4946-4954. PubMed ID: 30957179
[TBL] [Abstract][Full Text] [Related]
15. miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.
Xue J; Niu YF; Huang J; Peng G; Wang LX; Yang YH; Li YQ
Tumour Biol; 2014 Dec; 35(12):12103-7. PubMed ID: 25142234
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SNHG5 promotes glioma progression via miR-205/E2F3 axis.
Li X; Liu L; Luo Y; Cui S; Chen W; Zeng A; Shi Y; Luo L
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31292168
[TBL] [Abstract][Full Text] [Related]
17. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.
Wang L; Shi ZM; Jiang CF; Liu X; Chen QD; Qian X; Li DM; Ge X; Wang XF; Liu LZ; You YP; Liu N; Jiang BH
Oncotarget; 2014 Jul; 5(14):5416-27. PubMed ID: 24980823
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma.
Yang JK; Yang JP; Tong J; Jing SY; Fan B; Wang F; Sun GZ; Jiao BH
J Neurooncol; 2017 Jan; 131(2):255-265. PubMed ID: 27837435
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-217 functions as a prognosis predictor and inhibits pancreatic cancer cell proliferation and invasion via targeting E2F3.
Yang J; Zhang HF; Qin CF
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4050-4057. PubMed ID: 29028097
[TBL] [Abstract][Full Text] [Related]
20. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3.
Xu Y; Huang Z; Liu Y
Mol Med Rep; 2014 Nov; 10(5):2601-8. PubMed ID: 25231560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
